Biogen Buys $625 Million in Ionis Stock

Biogen disclosed in a regulatory filing last week that its holdings are the equivalent of a total stake of 8.4% in Ionis Pharmaceuticals after completing collaboration pact.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.